You are here: Home » News-CM » Companies » Results
Business Standard

Ajanta Pharma consolidated net profit declines 20.71% in the June 2017 quarter

Capital Market 

Sales decline 0.58% to Rs 473.12 crore

Net profit of declined 20.71% to Rs 94.79 crore in the quarter ended June 2017 as against Rs 119.55 crore during the previous quarter ended June 2016. Sales declined 0.58% to Rs 473.12 crore in the quarter ended June 2017 as against Rs 475.90 crore during the previous quarter ended June 2016. ParticularsQuarter EndedJun. 2017Jun. 2016% Var.Sales473.12475.90 -1 OPM %26.9434.87 -PBDT132.15171.02 -23 PBT118.73158.02 -25 NP94.79119.55 -21

Powered by Capital Market - Live News

(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)

First Published: Wed, August 09 2017. 17:18 IST
RECOMMENDED FOR YOU